Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00333112 · ClinicalTrials.gov registry record · Phase 4

A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.

A Phase 4 study of Urinary Incontinence, sponsored by Astellas Pharma.

Completed
Registry status
Phase 4
Development phase
398
Enrollment target
20
Study locations

NCT00333112 is a Phase 4 study of Urinary Incontinence that has completed, run by Astellas Pharma. The registered enrollment target is 398 participants, above the 254-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (57% higher). The trial reports 20 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00333112, a Phase 4 study of Urinary Incontinence, has completed, sponsored by Astellas Pharma.

COMPLETED
Registry status
Phase 4
Development phase
398 participants
Enrollment target
20
Study locations

Study Summary

A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men.

Conditions Studied

Urinary Incontinence

Interventions

  • DRUG placebo
  • DRUG solifenacin succinate
  • DRUG tamsulosin

Study Locations (20)

California

  • - Atherton
  • - Beverly Hills
  • - Buena
  • - Buena Park
  • - Carmichael
  • - Culver City
  • - Fresno
  • - Mission Hills
  • - Modesto
  • - Orange
  • - San Bernardino
  • - San Diego
  • - Torrance

Colorado

  • - Aurora
  • - Denver
  • - Wheat Ridge

Arizona

  • - Phoenix
  • - Tuscon

Alabama

  • - Birmingham

Connecticut

  • - Danbury

Trial Details

FieldValue
Enrollment Target 398 participants
Start Date 2006-05
Est. Completion 2007-01
Phase Phase 4

Sponsor

Astellas Pharma

165 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00333112

The ClinicalTrials.gov registry entry for NCT00333112 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 398 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 254-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (57% higher). The listed sponsor is Astellas Pharma, which has 165 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.

NCT00333112 reports 20 study locations spanning 5 distinct geographic areas - top geographies include California, Colorado, Arizona.

Frequently Asked Questions

What is clinical trial NCT00333112 about?

NCT00333112 is a clinical study titled "A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.". A study to evaluate solifenacin succinate in combination with tamsulosin for the treatment of residual OAB symptoms in men.

What is the current status of trial NCT00333112?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 398 participants. The study started on 2006-05. Estimated completion is 2007-01.

What conditions does trial NCT00333112 study?

This clinical trial studies the following conditions: Urinary Incontinence.

What interventions are being tested in trial NCT00333112?

The interventions under investigation include: placebo (DRUG), solifenacin succinate (DRUG), tamsulosin (DRUG).

Who is sponsoring clinical trial NCT00333112?

This trial is sponsored by Astellas Pharma, which has 165 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00333112 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Urinary Incontinence

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.